Management & Directors

 

MICHAEL NISTORESCU

Chief Executive Officer

Mr. Nistorescu  started  his career  as  an analyst  at  Gluskin Sheff  +  Associates and  went  on to  become  Investments Director at Infinite Potential Management. He then co-founded a boutique private equity firm where he served as CEO and Investments Director. Mr. Nistorescu earned a degree in Economics and International Studies from York University. He brings a wealth of experience in business strategy, asset allocation, and company management.

EDUARDO MAYORGA

President

Mr. Mayorga has worked for over fifteen years in the strategic management and development of projects throughout Colombia. He earned his MBA in strategic leadership from Andes University and his specialty in the management of human development from Rosario University. Mr. Mayorga brings expertise in managing teams and projects in Colombia.

PAUL ROBERTSON

Chief Financial Officer

Mr. Robertson is a Chartered Professional Accountant with extensive experience in the mining sector. In addition to CannaVerde, Mr. Robertson is the managing partner of Quantum Advisory Partners LLP, which assists public companies with financial reporting, taxation and regulatory requirements. He was previously the CFO of Grayd Resource Corporation (acquired by Agnico Eagle). Mr. Robertson holds a BA from the University of Western Ontario. He brings expertise in financial reporting.

IVAN OSSMA

Chief Medical Officer

Dr. Ossma is currently a Clinical Professor of Ophthalmology at ICESI University and the Head of Anterior Segment Surgery at Fundación Valle del Lili, both in Colombia. He graduated as a Medical Doctor from Pontificia Universidad Javeriana and obtained a Masters in Public Health from John Hopkins University and a Masters in Science in Clinical Epidemiology from Harvard T.H. Chan School of Public Health. Dr. Ossma has performed more than 25,000 surgeries around the globe. Dr. Ossma has been involved in numerous FDA monitored clinical trials. In the past he has served as an advisory board member for Abbott Laboratories and Novartis. Dr. Ossma possesses a strong scientific and clinical background with abilities to bridge the gaps between conceptual products and patient-centric needs in multiple fields of medicine and personal care products. 

DANIEL OSSMA

Chief Commercial Officer

Mr. Ossma has worked for over fifteen years in the pharmaceutical industry in Latin America. Most recently, Mr. Ossma served as the Head of Hematology Business Franchise for Novartis in Ecuador and Peru. Mr. Ossma will be responsible for spearheading CannaVerde’s commercial and operational strategy for Latin America, where he will structure and re-enforce the company’s abilities to partner with key players in the consumer market, ensure innovative products are brought to consumers and develop the company’s long-term market strategy.  

PETER CHEN

Chief Science Officer

Dr. Chen holds a PhD in Food Science from the University of Guelph where he was the recipient of the Governor General’s Academic Gold Medal for academic excellence. His PhD focused on plant bioactive molecules with antioxidant and anti-inflammatory activities. Dr. Chen’s research resulted in 20 peer-reviewed publications and numerous articles on a wide variety of topics related to cannabis research. He has experience working as Lead Scientist and VP of Science for two licensed cannabis producers in Canada. Dr. Chen brings expertise in extraction, product formulation, and scientific research.   

 

Board of Directors

 

MICHAEL NISTORESCU

Mr. Nistorescu  started  his career  as  an analyst  at  Gluskin Sheff  +  Associates and  went  on to  become  Investments Director at Infinite Potential Management. He then co-founded a boutique private equity firm where he served as CEO and Investments Director. Mr. Nistorescu earned a degree in Economics and International Studies from York University. He brings a wealth of experience in business strategy, asset allocation, and company management.

PAUL ROBERTSON

Mr. Robertson is a Chartered Professional Accountant with extensive experience in the mining sector. In addition to CannaVerde, Mr. Robertson is the managing partner of Quantum Advisory Partners LLP, which assists public companies with financial reporting, taxation and regulatory requirements. He was previously the CFO of Grayd Resource Corporation (acquired by Agnico Eagle). Mr. Robertson holds a BA from the University of Western Ontario. He brings expertise in financial reporting.

Shane Shircliff

Shane Shircliff has over 20 years of experience in executive management and corporate director roles for both publicly traded and private companies and has extensive experience with the TSX Venture Exchange. Industries of experience include logistics, finance, natural resources, exploration and mining, real estate and construction. Mr. Shircliff has been directly involved with all aspects of developing resource projects encompassing lithium, uranium, gold, silver, industrial minerals, diamonds as well as oil and gas in a variety of countries. Mr. Shircliff is the founder and CEO of Clinworth Management Corp., a private company, which provides management, acquisition, divestiture and corporate development services to a wide range of clients. Clinworth most recently has been working with and advising clients in the areas of resources, retail, real estate and construction. In addition to industry clients, Clinworth continues to advise First Nations bands and their economic development entities on strategy, negotiation and growth opportunities. Mr. Shircliff has a Bachelor of Commerce (Finance and Economics) and a Masters of Business Administration both from the University of Saskatchewan.

Marc Johnson

Marc Johnson is a bilingual senior executive with over 20 years of business experience, including 10 years at public corporations as CFO, VP Corporate Development and other financial management positions, and 10 years in capital markets in investment banking and equity research. Mr. Johnson is a Chartered Financial Analyst (CFA) and a Chartered Professional Accountant (CPA). Currently, Mr. Johnson is the CFO of NextSource Materials Inc. (TSXV) and International Corona Capital Corp. (TSXV). He also holds a Bachelor of Commerce (Finance) from the John Molson School of Business at Concordia University in Montreal.

 

ADVISORY BOARD MEMBERS

 
 

CARLOS ULLOA

Dr. Ulloa is a medical doctor specializing in sports medicine with more than 10 years experience caring for the well-being of performance athletes in Colombia. Dr. Ulloa graduated from the Pontificia Universidad Javeriana and the Universidad Del Bosque. Dr. Ulloa served in the position of team physician for Colombia’s National Soccer team for the past 10 years. He also served as the team physician for the Olympic Team, FEDETENIS and CONMEBOL. His experience offers unique insight and depth in understanding how the benefits of medical cannabis derivatives will be integrated in the field of professional and consumer sports performance. 

JAVIER PATINO

Mr. Patiño is an Industrial Engineer with more than 38 years experience in the Fast-Moving Consumer Goods companies in Latin America. As a General Manager, Mr. Patiño has worked for both Yanbal and Quaker Oats. During his 5-year career at Yanbal, Mr. Patiño achieved an increase in revenues from USD $50 million to over USD $200 million. He has participated in over 150 new product launches throughout Latin America. He graduated from the Universidad de Los Andes (Colombia) and from the Wharton Business School and the University of Pennsylvania. 

LUIS VILLEGAS

Dr. Villegas has worked as an anesthesiologist specializing in acute and chronic pain management for over 15 years. Dr. Villegas is one of the founders of one of the most recognized ophthalmology clinics in Medellin, Colombia. He graduated from the U.P.B. School of Medicine and from the Universidad del Valle in Cali. He earned his MBA from EAFIT University in Medellin. Since 2014, Dr. Villegas has served as the President of OCCULUS Corp., a company focused on commercializing medical tourism to Latin America.